← brief for 2026-10-02 · Slowing decline

Combination Therapy of Romiplostim and Erythropoiesis-stimulating Agents

Key takeaways

This trial is starting to test a drug called romiplostim for people on dialysis. It will check if adding this drug to standard anemia treatment is safe. There are no results yet. The study will look at blood cell counts and side effects.

Who did this work

Run by Chinese University of Hong Kong.
Sites: The Chinese University of Hong Kong

Source

Trial · ClinicalTrials.gov, CKD recruiting · 2026-10-02
https://clinicaltrials.gov/study/NCT07854561